These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3564137)

  • 21. Diabetic renal disease in blacks--inevitable or preventable?
    Rostand SG
    N Engl J Med; 1989 Oct; 321(16):1121-2. PubMed ID: 2797070
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney disease and hypertension in blacks.
    Striker GE
    Am J Kidney Dis; 1992 Dec; 20(6):673. PubMed ID: 1463002
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus.
    Garza R; Medina R; Basu S; Pugh JA
    Am J Nephrol; 1997; 17(1):59-67. PubMed ID: 9057955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical therapy for renal failure in blacks--urban US geographic perspectives.
    Dillard MG
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):63-6. PubMed ID: 3564140
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.
    August P; Leventhal B; Suthanthiran M
    Curr Hypertens Rep; 2000 Apr; 2(2):184-91. PubMed ID: 10981147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension does not contribute to end-stage renal disease in black recipients of kidney/pancreas transplants.
    Froelich J; Posner M; Beck R; Tesi RJ
    Transplant Proc; 1997 Dec; 29(8):3718. PubMed ID: 9414899
    [No Abstract]   [Full Text] [Related]  

  • 27. Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes.
    Lee J; Chu C; Guzman D; Fontil V; Velasquez A; Powe NR; Tuot DS
    Am J Nephrol; 2019; 50(1):48-54. PubMed ID: 31167180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
    Owen WF
    Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus--United States, 1980-1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):834-7. PubMed ID: 1435669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The excess risk of treated end-stage renal disease in blacks in the United States.
    Lopes AA; Port FK; James SA; Agodoa L
    J Am Soc Nephrol; 1993 Jun; 3(12):1961-71. PubMed ID: 8338929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For the patient. African-American women at risk of diabetes and kidney disease. Advanced diabetic nephropathy disproportionately affects African-American females: cross-sectional analysis and determinants of renal survival in an academic renal clinic.
    Crook ED; Wofford P; Oliver B
    Ethn Dis; 2003; 13(1):147. PubMed ID: 12723024
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why does uremia in heroin abusers occur predominantly among blacks?
    Friedman EA; Rao TK
    JAMA; 1983 Dec; 250(21):2965-6. PubMed ID: 6644974
    [No Abstract]   [Full Text] [Related]  

  • 37. The problem of diabetic renal failure in the United States: an overview.
    Teutsch S; Newman J; Eggers P
    Am J Kidney Dis; 1989 Jan; 13(1):11-3. PubMed ID: 2912060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of chronic progressive renal disease in the African American patient with hypertension.
    Neal L; Greene EL
    Am J Med Sci; 2002 Feb; 323(2):72-7. PubMed ID: 11863082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.